Efficacy of compound oxymatrine injection combination with postoperative chemotherapy for advanced ovarian carcinoma
10.3760/cma.j.issn.1673-4904.2012.12.008
- VernacularTitle:复方苦参注射液联合化疗在晚期卵巢癌中的综合疗效研究
- Author:
Zixi WANG
;
Yonghua JIANG
- Publication Type:Journal Article
- Keywords:
Sophora flavescens;
Ovarian neoplasms;
Drug therapy
- From:
Chinese Journal of Postgraduates of Medicine
2012;35(12):21-23
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo evaluate the effect of compound oxymatrine injection combination with chemotherapy in patients with advanced ovarian carcinoma.MethodsEighty-six patients with advanced ovarian carcinoma were divided by random digits table method into observation group(43 cases) receiving compound oxymatrine injection plus chemotherapy(paclitaxel plus carboplatin) and control group (43cases) treated with chemotherapy(p aclitaxel plus carboplatin) alone.The change of white blood cell,adverse reaction and effect of the patients were observed.ResultsThe white blood cell of observation group after treatment was obviously higher than that of control group [ (4.7 ± 1.4) × 109/L vs.(3.2 ± 1.6) × 109/L,P ＜ 0.05 ].The rates of nausea and vomiting,transaminase elevating and kidney damage of observation group were obviously lower than those of control group[ 16.3％ (7/43),14.0％ (6/43),20.9％ (9/43) vs.34.9％(15/43),32.6％ (14/43),44.2％ ( 19/43 ),P ＜ 0.05 ].The complete remission rate of observation group was significantly higher than that of control group[55.8％(24/43) vs.27.9％(12/43),P ＜ 0.05].Conclusion Addition of compound oxymatrine injection to chemotherapy for patients with advanced ovarian carcinoma can effectively protect patients against the decreasing of the white blood cell and attenuate the side effects brought by chemotherapy.
